Filipe S. Dutra-Pereira
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Sepsis-induced lipid droplet accumulation enhances antibacterial innate immunity through mechanisms dependent on DGAT-1 and interferon-beta.
Journal: Metabolism: clinical and experimental
Published: March 01, 2025
Cannabinoid receptor type 2 agonist GP1a attenuates macrophage activation induced by M. bovis-BCG by inhibiting NF-κB signaling.
Journal: Journal of leukocyte biology
Published: July 18, 2024
HSV1-induced enhancement of productive HIV-1 replication is associated with interferon pathway downregulation in human macrophages.
Journal: Memorias do Instituto Oswaldo Cruz
Published: May 02, 2024
Accumulation of lipid droplets induced by Listeria monocytogenes in macrophages: implications for survival and evasion of innate immunity.
Journal: Journal of leukocyte biology
Published: January 30, 2024
Lipid compartments and lipid metabolism as therapeutic targets against coronavirus.
Journal: Frontiers in immunology
Published: July 28, 2023
Prevention of lipid droplet accumulation by DGAT1 inhibition ameliorates sepsis-induced liver injury and inflammation.
Journal: JHEP reports : innovation in hepatology
Published: February 28, 2023
Metabolic reprogramming and lipid droplets are involved in Zika virus replication in neural cells.
Journal: Journal of neuroinflammation
Published: October 25, 2022
Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages.
Journal: Frontiers in cellular and infection microbiology
Published: October 11, 2022
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones.
Journal: Viruses
Published: June 10, 2022
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation.
Journal: Nature communications
Published: April 14, 2022
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way.
Journal: Journal of molecular cell biology
Published: February 04, 2022
Last Updated: 09/26/2026